HomePIRS • NASDAQ
add
Pieris Pharmaceuticals Inc
Previous close
$15.94
Day range
$15.89 - $16.97
Year range
$6.28 - $22.32
Market cap
22.15M USD
Avg Volume
27.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.14M | -54.16% |
Net income | -2.89M | 73.15% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.14M | -181.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.36M | -56.79% |
Total assets | 20.52M | -65.44% |
Total liabilities | 4.25M | -85.26% |
Total equity | 16.27M | — |
Shares outstanding | 1.32M | — |
Price to book | 1.29 | — |
Return on assets | -34.40% | — |
Return on capital | -44.82% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.89M | 73.15% |
Cash from operations | 146.00K | 101.50% |
Cash from investing | 142.00K | 107.16% |
Cash from financing | — | — |
Net change in cash | -368.00K | 96.94% |
Free cash flow | 109.62K | 100.65% |
About
Founded
2001
Headquarters
Website
Employees
48
